These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 8097790

  • 1. Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV).
    Oie S, Jacobson MA, Abrams DI.
    J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):531-3. PubMed ID: 8097790
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Surrogate markers for AIDS treatment.
    Jacobson M.
    Nurs Times; 1993 May; 87(22):49. PubMed ID: 1675013
    [No Abstract] [Full Text] [Related]

  • 4. Serum levels of soluble CD8, neopterin, beta 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy.
    Siller L, Martin NL, Kostuchenko P, Beckett L, Rautonen J, Cheng SC, Wara DW.
    AIDS; 1993 Mar; 7(3):369-73. PubMed ID: 8097095
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD4, soluble CD8, and soluble interleukin-2 receptor levels in patients with AIDS or AIDS-related complex treated with 2',3'-dideoxyinosine (ddI).
    Reddy MM, McKinley GF, Grieco MH.
    J Clin Lab Anal; 1991 Mar; 5(6):396-8. PubMed ID: 1774603
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum calprotectin levels in HIV-infected patients: the calprotectin response during ZDV treatment is associated with clinical events.
    Müller F, Frøland SS, Aukrust P, Fagerhol MK.
    J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):931-9. PubMed ID: 7914232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
    Crocchiolo PR, Lizioli A, Arcidiacono I, Cantaluppi P, Filippi C, Sobatti D, Bedarida G, D'Agostino F, Cambie G, Nardella ML.
    Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
    [Abstract] [Full Text] [Related]

  • 10. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
    Lafeuillade A, Tamalet C, Pellegrino P, de Micco P, Vignoli C, Quilichini R.
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.
    Gulevich SJ, McCutchan JA, Thal LJ, Kirson D, Durand D, Wallace M, Mehta P, Heyes MP, Grant I.
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1002-7. PubMed ID: 8101873
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection.
    Fuchs D, Krämer A, Reibnegger G, Werner ER, Dierich MP, Goedert JJ, Wachter H.
    Infection; 1991 Sep; 19 Suppl 2():S98-102. PubMed ID: 1673120
    [Abstract] [Full Text] [Related]

  • 17. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P.
    Ann Intern Med; 1995 Apr 15; 122(8):573-9. PubMed ID: 7887550
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group.
    Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT.
    J Acquir Immune Defic Syndr (1988); 1993 Jul 15; 6(7):787-94. PubMed ID: 8099612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.